Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin (IL)‐33: an orchestrator of immunity from host defence to tissue homeostasis
Zekun Zhou, Fei Yan, Ousheng Liu
Clinical & Translational Immunology (2020) Vol. 9, Iss. 6
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Elizabeth England, D. Gareth Rees, Ian C. Scott, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 51
IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity
Corinne Cayrol
Cells (2021) Vol. 11, Iss. 1, pp. 107-107
Open Access | Times Cited: 64
Cell–scaffold interactions in tissue engineering for oral and craniofacial reconstruction
Fushi Wang, Xinjie Cai, Ya Shen, et al.
Bioactive Materials (2022) Vol. 23, pp. 16-44
Open Access | Times Cited: 61
Innate Immunity and Asthma Exacerbations: Insights From Human Models
Jehan Alladina, Benjamin D. Medoff, Christina Schofield
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
IL-33 biology in cancer: An update and future perspectives
Wen Jie Yeoh, Vivian Vu, Philippe Krebs
Cytokine (2022) Vol. 157, pp. 155961-155961
Open Access | Times Cited: 36
Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions
Han Guo, Elhusseny A. Bossila, Xinran Ma, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3237-3237
Open Access | Times Cited: 27
Targeting Oncoimmune Drivers of Cancer Metastasis
Chie Kudo‐Saito, Yukinori Ozaki, Hiroshi Imazeki, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 554-554
Open Access | Times Cited: 21
IL-33 Deficiency Attenuates Lung Inflammation by Inducing Th17 Response and Impacting the Th17/Treg Balance in LPS-Induced ARDS Mice via Dendritic Cells
Li Cheng, Yang Jiao, Wei Jiang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 15
Cytokine patterns in the blister fluid and plasma of patients with fracture blisters
Yiran Li, Yubin Long, Xiaojun Chen, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110738-110738
Open Access | Times Cited: 7
Decoding the IL-33/ST2 Axis: Its Impact on the Immune Landscape of Breast Cancer
Bojan Stojanović, Nevena Gajović, Milena Jurišević, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14026-14026
Open Access | Times Cited: 7
Hepatic pannexin‐1 mediates ST2 + regulatory T cells promoting resolution of inflammation in lipopolysaccharide ‐induced endotoxemia
Pusen Wang, Baojie Shi, Wang Chunguang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 11
Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury
Guy J. M. Cameron, Simon Jiang, Svenja Loering, et al.
The Journal of Pathology (2019) Vol. 248, Iss. 1, pp. 9-15
Open Access | Times Cited: 16
IL-33/ST2 Axis Deficiency Exacerbates Hepatic Pathology by Regulating Treg and Th17 Cells in Murine Schistosomiasis Japonica
Yang Bai, Fei Guan, Feifan Zhu, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 5981-5998
Open Access | Times Cited: 13
IL-13 Controls IL-33 Activity through Modulation of ST2
Melvin Zhang, Jennifer Duffen, Karl Nocka, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 12, pp. 3070-3080
Open Access | Times Cited: 13
Regulatory T cells-centered regulatory networks of skeletal muscle inflammation and regeneration
Ziyu Chen, Haiqiang Lan, Zhaohong Liao, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
IL‐33/ST2 axis deficiency exacerbates neutrophil‐dominant allergic airway inflammation
Qiyun Ma, Yan Qian, Jingxian Jiang, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 6
Open Access | Times Cited: 12
Adiponectin and Interleukin-33: Possible Early Markers of Metabolic Syndrome
Jelena Nešić, Biljana Ljujić, Vesna Rosic, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 132-132
Open Access | Times Cited: 8
Cytokine profile of the epidermis is region specific and may determine the characteristics of inflammation
Lilla Szabó, Zsolt Dajnoki, Orsolya Somogyi, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 7, pp. 1120-1131
Open Access | Times Cited: 4
Psychoses by attacks from subverted mast cells: A role for arterial intramural flow badly steered by the nasal ganglia?
G. R. Treviranus
Psychiatria Danubina (2020) Vol. 32, pp. 93-104
Closed Access | Times Cited: 11
Interleukin-33: Metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells
Jian Lin, Jiyun Liu, Rui Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
IL-33 ameliorates liver injury and inflammation in Poly I:C and Concanavalin-A induced acute hepatitis
Hilal Ahmad Khan, Tariq Munir, Junaid Khan, et al.
Microbial Pathogenesis (2020) Vol. 150, pp. 104716-104716
Closed Access | Times Cited: 8
Phosphonate-Modified Cellulose Nanocrystals Potentiate the Th1 Polarising Capacity of Monocyte-Derived Dendritic Cells via GABA-B Receptor
Marina Bekić, Miloš Vasiljević, Dušica Stojanović, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3191-3216
Open Access | Times Cited: 5
Applications of nanochitosan in the detection and control of aquatic diseases
Ogundolie Frank Abimbola, Titilayo M. Olotu, Charles Oluwaseun Adetunji, et al.
Elsevier eBooks (2023), pp. 221-234
Closed Access | Times Cited: 2
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
Chie Kudo‐Saito, Narikazu Boku, Hidekazu Hirano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Targeting Myeloid Determinants of Breast Cancer
Chie Kudo‐Saito, Yukinori Ozaki
(2024), pp. 255-285
Closed Access
Page 1 - Next Page

Scroll to top